63459-395 : Treanda 45 mg/.5ml Intravenous Injection, Solution, Concentrate
| NDC: | 63459-395 |
| Labeler: | Cephalon, Incorporated |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Treanda |
| Dosage Form: | Intravenous Injection, Solution, Concentrate |
| Application #: | NDA022249 |
| Rev. Date: |
NDC Package Codes:
- 63459-395-02: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (63459‑395‑02) > .5 ML IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Bendamustine Hydrochloride
Dosage Strength:
- 45 mg/.5mL
Pharmaceutical Classes:
- Alkylating Activity [MoA]
- Alkylating Drug [EPC]
Related Products:
Based on records with the same trade name.- 63459-396 Treanda 180 mg/2ml Intravenous Injection, Solution, Concentrate by Cephalon, Incorporated
- 63459-390 Treanda 25 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Cephalon, Inc.
- 63459-391 Treanda 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Cephalon, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 63459-391Next: 63459-396 >
Related Discussions:
Treanda side effects
I took my first treatment on 12/22, 12/23 for PLL. I have had constant headaches, fevers and chills going on two weeks n... 2 replies
I took my first treatment on 12/22, 12/23 for PLL. I have had constant headaches, fevers and chills going on two weeks n... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.